Summary
The global Ioversol market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Ioversol 34% Injectable Solution (Optiray 160)
Ioversol 51% Injectable Solution (Optiray 240)
Ioversol 64% Injectable Solution (Optiray 300)
Ioversol 68% Injectable Solution (Optiray 320)
Ioversol 74% Injectable Solution (Optiray 350)
Demand Coverage (Market Size & Forecast, Consumer Distribution):
X-ray
CT Scan
Brain Disorders
Blood Vessel Disorders
Heart Disorders
Others
Company Coverage (Sales data, Main Products & Services etc.):
Liebel-Flarsheim Company LLC
Guerbet
Jiangsu Hengrui Medicine Co
Mallinckrodt Pharmaceuticals
Ultraject
China Resources Pharmaceutical (Shanghai) Co
HB Ocean
Novalek Pharmaceuticals Pvt. Ltd
Stellence Pharmscience Pvt. Ltd
A.S. Joshi & Company
Major Region Market
North America
Europe
Asia-Pacific
South America
Middle East & Africa
The global Ioversol market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Ioversol 34% Injectable Solution (Optiray 160)
Ioversol 51% Injectable Solution (Optiray 240)
Ioversol 64% Injectable Solution (Optiray 300)
Ioversol 68% Injectable Solution (Optiray 320)
Ioversol 74% Injectable Solution (Optiray 350)
Demand Coverage (Market Size & Forecast, Consumer Distribution):
X-ray
CT Scan
Brain Disorders
Blood Vessel Disorders
Heart Disorders
Others
Company Coverage (Sales data, Main Products & Services etc.):
Liebel-Flarsheim Company LLC
Guerbet
Jiangsu Hengrui Medicine Co
Mallinckrodt Pharmaceuticals
Ultraject
China Resources Pharmaceutical (Shanghai) Co
HB Ocean
Novalek Pharmaceuticals Pvt. Ltd
Stellence Pharmscience Pvt. Ltd
A.S. Joshi & Company
Major Region Market
North America
Europe
Asia-Pacific
South America
Middle East & Africa
Table of Content
1 Industry Overview
1.1 Ioversol Industry
1.1.1 Overview
1.1.2 Products of Major Companies
1.2 Market Segment
1.2.1 Industry Chain
1.2.2 Consumer Distribution
1.3 Price & Cost Overview
2 Ioversol Market by Type
2.1 By Type
2.1.1 Ioversol 34% Injectable Solution (Optiray 160)
2.1.2 Ioversol 51% Injectable Solution (Optiray 240)
2.1.3 Ioversol 64% Injectable Solution (Optiray 300)
2.1.4 Ioversol 68% Injectable Solution (Optiray 320)
2.1.5 Ioversol 74% Injectable Solution (Optiray 350)
2.2 Market Size by Type
2.3 Market Forecast by Type
3 Global Market Demand
3.1 Segment Overview
3.1.1 X-ray
3.1.2 CT Scan
3.1.3 Brain Disorders
3.1.4 Blood Vessel Disorders
3.1.5 Heart Disorders
3.1.6 Others
3.2 Market Size by Demand
3.3 Market Forecast by Demand
4 Major Region Market
4.1 Global Market Overview
4.1.1 Market Size & Growth
4.1.2 Market Forecast
4.2 Major Region
4.2.1 Market Size & Growth
4.2.2 Market Forecast
5 Major Companies List
5.1 Liebel-Flarsheim Company LLC (Company Profile, Sales Data etc.)
5.2 Guerbet (Company Profile, Sales Data etc.)
5.3 Jiangsu Hengrui Medicine Co (Company Profile, Sales Data etc.)
5.4 Mallinckrodt Pharmaceuticals (Company Profile, Sales Data etc.)
5.5 Ultraject (Company Profile, Sales Data etc.)
5.6 China Resources Pharmaceutical (Shanghai) Co (Company Profile, Sales Data etc.)
5.7 HB Ocean (Company Profile, Sales Data etc.)
5.8 Novalek Pharmaceuticals Pvt. Ltd (Company Profile, Sales Data etc.)
5.9 Stellence Pharmscience Pvt. Ltd (Company Profile, Sales Data etc.)
5.10 A.S. Joshi & Company (Company Profile, Sales Data etc.)
6 Conclusion
1 Industry Overview
1.1 Ioversol Industry
1.1.1 Overview
1.1.2 Products of Major Companies
1.2 Market Segment
1.2.1 Industry Chain
1.2.2 Consumer Distribution
1.3 Price & Cost Overview
2 Ioversol Market by Type
2.1 By Type
2.1.1 Ioversol 34% Injectable Solution (Optiray 160)
2.1.2 Ioversol 51% Injectable Solution (Optiray 240)
2.1.3 Ioversol 64% Injectable Solution (Optiray 300)
2.1.4 Ioversol 68% Injectable Solution (Optiray 320)
2.1.5 Ioversol 74% Injectable Solution (Optiray 350)
2.2 Market Size by Type
2.3 Market Forecast by Type
3 Global Market Demand
3.1 Segment Overview
3.1.1 X-ray
3.1.2 CT Scan
3.1.3 Brain Disorders
3.1.4 Blood Vessel Disorders
3.1.5 Heart Disorders
3.1.6 Others
3.2 Market Size by Demand
3.3 Market Forecast by Demand
4 Major Region Market
4.1 Global Market Overview
4.1.1 Market Size & Growth
4.1.2 Market Forecast
4.2 Major Region
4.2.1 Market Size & Growth
4.2.2 Market Forecast
5 Major Companies List
5.1 Liebel-Flarsheim Company LLC (Company Profile, Sales Data etc.)
5.2 Guerbet (Company Profile, Sales Data etc.)
5.3 Jiangsu Hengrui Medicine Co (Company Profile, Sales Data etc.)
5.4 Mallinckrodt Pharmaceuticals (Company Profile, Sales Data etc.)
5.5 Ultraject (Company Profile, Sales Data etc.)
5.6 China Resources Pharmaceutical (Shanghai) Co (Company Profile, Sales Data etc.)
5.7 HB Ocean (Company Profile, Sales Data etc.)
5.8 Novalek Pharmaceuticals Pvt. Ltd (Company Profile, Sales Data etc.)
5.9 Stellence Pharmscience Pvt. Ltd (Company Profile, Sales Data etc.)
5.10 A.S. Joshi & Company (Company Profile, Sales Data etc.)
6 Conclusion
